Better Outcome of Coronavirus Disease 2019 Infection in Kidney Transplant Recipients: A Case Series from Eastern India

Saudi J Kidney Dis Transpl. 2021 May-Jun;32(3):875-879. doi: 10.4103/1319-2442.336787.

Abstract

The coronavirus disease 2019 (COVID-19) led to a global pandemic which is still unfolding. Little is known about the presentation, course of disease, treatment, and outcome in kidney transplant recipients. In this series, we describe nine such patients who presented with COVID-19. The mean age of the patients was 41.22 years. The mean duration of kidney transplantation was 63.22 months. The most common symptom was fever (9/9), followed by malaise (7/9), cough (5/9), dyspnea (4/9), diarrhea (2/9), and hemoptysis (2/9). Five patients developed acute kidney injury. Antiproliferative was stopped in all cases. Three patients needed hospitalization due to hypoxia while others were managed at home. We observed that majority of patients could be managed at home with isolation and self-monitoring. Even patents with moderate-to-severe disease were managed with oxygen supplement, low molecular weight heparin, and remdesivir. All patients recovered without any short-term sequelae in two months follow-up.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury*
  • Adult
  • COVID-19 / complications*
  • Humans
  • Immunocompromised Host
  • Kidney Transplantation / adverse effects
  • Middle Aged
  • SARS-CoV-2
  • Transplant Recipients / statistics & numerical data*